ArticleResearch square2026

Integrating genetically predicted transcriptomic signatures with longitudinal real-world data enables scalable drug repurposing for Alzheimer's disease.

Monika E Grabowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.